Aromasin Alternatives Compared
Aromasin | Ribociclib | Alpelisib |
|
---|
Aromasin (exemestane) | Ribociclib | Alpelisib |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Aromasin is a brand (trade) name for exemestane which is a medication that is used to treat breast cancer in postmenopausal women. It is often given to women whose cancer has progressed despite... View more |
Prescription only
Prescribed for Breast Cancer - Metastatic, Breast Cancer. ribociclib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for PIK3CA-Related Overgrowth Spectrum, Breast Cancer, Breast Cancer - Male. alpelisib may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||
More about Aromasin (exemestane) | More about Ribociclib | More about Alpelisib | ||||||||
Ratings & Reviews | ||||||||||
Aromasin has an average rating of 4.9 out of 10 from a total of 24 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 41% reported a negative effect. |
Ribociclib has an average rating of 8.3 out of 10 from a total of 29 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 8% reported a negative effect. |
Alpelisib has an average rating of 6.3 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Aromasin side effects in more detail. |
See also: ribociclib side effects in more detail. |
See also: alpelisib side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
View all Aromasin prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | ||||||||||
|
N/A |
N/A |
||||||||
Brand Names | ||||||||||
N/A |
Kisqali | Piqray, Vijoice | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
24 hours |
54.7 hours |
9 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 91 drugs are known to interact with Aromasin:
|
A total of 708 drugs are known to interact with ribociclib:
|
A total of 313 drugs are known to interact with alpelisib:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
October 21, 1999 |
March 13, 2017 |
May 24, 2019 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
|||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.